3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Malignant Pleural Mesothelioma: new trials by email Literature Review of Malignant Pleural Mesothelioma trials Research Report on Malignant Pleural Mesothelioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma Durvalumab, Standard Chemotherapy, Ipilimumab and Nivolumab - Mesothelioma, Pleural Mesothelioma | Phase 3 | Completed | PrECOG, LLC. | 214 | 2021-02-18 | 2026-10-22 |
| Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma rAd-IFN, Celecoxib Oral Product, Gemcitabine - Malignant Pleural Mesothelioma | Phase 3 | Completed | Ferring Ventures Limited | 53 | 2019-01-21 | 2026-04-21 |
| NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed NGR-hTNF plus Best Investigator's Choice (BIC), Placebo plus Best Investigator's Choice (BIC) - Malignant Pleural Mesothelioma | Phase 3 | Completed | AGC Biologics S.p.A. | 400 | 2010-04-12 | 2019-09-17 |
Mesothelioma, Malignant (3) · Mesothelioma (1)
Adenoma (3) · Lung Diseases (3) · Lung Neoplasms (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Mesothelial (3) · Pleural Neoplasms (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Mesothelioma (2)
Carboplatin (1) · Cisplatin (1) · Drug Therapy (1) · Gemcitabine (1) · Ipilimumab (1) · Nivolumab (1) · Pemetrexed (1) · durvalumab (1) · tumor necrosis factor-alpha, CNGRC fusion protein, human (1)
AGC Biologics S.p.A. (1) · Ferring Ventures Limited (1) · PrECOG, LLC. (1)
United States (3) · Australia (2) · Canada (2) · France (2) · Italy (2) · Poland (2) · United Kingdom (2) · Belgium (1) · Egypt (1) · Germany (1) · Ireland (1) · Netherlands (1) · New Zealand (1) · Russia (1) · Spain (1)
Anna Nowak, MD (1) · Antonio Lambiase, MD (1) · Daniel Sterman, MD (1) · Patrick Forde, MD (1)
PMID 29753703, PMID 33358660, PMID 34499875
2009 (1), 2017 (1)